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Abstract 
Actinomycetes are considered as the most invaluable prokaryotes whose genome mining 
show a great number of putative secondary metabolite biosynthesis pathways as well as gene 
clusters ranging from 20 to 50 per genome. The genus Streptomyces has been explored for its 
ability to produce 60% antibiotics worldwide. Alnus nepalensis  (Alder) has been found to 
harbor diverse Eubacteria in its rhizosphere. To evaluate the antibiotic production potential 
from Actinomycetes, we collected soil samples from rhizosphere (5-7 cm deep) of Alder tree. 
Primary screening was done by cross-streak method against Multidrug Resistant (MDR) such 
as Methicillin resistant Staphylococcus auereus (MRSA), Vancomycin resistant Enterococcus 
feacalis (VRE), Imepenem resistant Acinetobacterbaumannii, Vancomycin resistant Klebsiella 
pneumonia and Imepenem resistant E. coli as well as Non-MDRs (E. coli, Bacillus subtilis, 
Klebsiella pneumoniae, S. aeureu and Enterococcus feacalis). Extraction of antibiotics was done 
using rota-vapour from extract obtained by solid-substrate fermentation technique followed 
by solvent extraction. Secondary screening was done using well diffusion assay against 
MDRs. Among total of 40 isolates of Actinomycetes recovered, 14 showed remarkable zone of 
inhibition (ZOI) to various MDRs. NASA 303 showed 26 mm of ZOI against VRE, NASA 101 
had ZOI of 34 mm against MRSA, NASA 319 had 33.7 mm ZOI against Imepenem resistant E. 
coli, NASA 306 had 36 mm of ZOI against Vancomycin resistant Klebsiella pneumoniae, and 
NASA 108 showed ZOI of 29.6 mm against Imepenem resistant E. faecalis. This investigation 
revealed that the Actinomycetes found in Rhizosphere of Alder tree had MDR killing potent 
antibiotics, which needs to be further explored. 
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Introduction 
Nepal is a narrow rectangular country in the 
Himalayas. It is bounded by cold, arid Tibetan 
plateau in north and hot humid planes to the 
south. Being a transition zone between the two 
extremes of north and south, the vegetation and 
the microbes in this goldilocks zone has thrived 
spectacularly. The alder (Alnus nepalensis) of 
Nepal [1] is one of the examples for the 
diversified ecosystem, which houses amazing 
diversity of microbes within its rhizosphere 
region. Alder is semi-deciduous tree; present 
throughout the Himalaya at 500-3000m elevation 
from Pakistan through Nepal and Bhutan to 
Yunnan in southwest China. Moreover, the Alder 
houses microbes capable of producing 
antimicrobial metabolites that prevents it from 
being infected by different pathogenic fungi and 
bacteria. Its rhizosphere can be screened in-
search of novel antibiotic producing microbes [2]. 
Actinomycetes are filamentous bacteria that 
belong to the phyla Actinobacteria and the order 
Actinomycetales. Actinomycetes are considered 
as the most invaluable prokaryotes in medicinal 
and biotechnology industries because of their 
ability to produce number of bioactive molecules, 
particularly of the antibiotic compounds. 
Streptomyces that belong to the genus 
Actinomycetes has been considered for the 
production of 60% of the antibiotics [3-5]. 
The rapidly decreasing costs of genome 
sequencing has made genome mining, an 
invaluable resource for drug discovery: A great 
number of putative secondary metabolite 
biosynthesis pathways have been discovered 
using these genome data [6, 7]. In Actinomycetes 
species, about 20-50 gene clusters per genome 
encoding pathways for secondary metabolite 
biosynthesis are present [6, 8]. Intriguingly, a 
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large number of these pathways are cryptic: they 
are not expressed under standard laboratory 
conditions, and their products are therefore 
unknown. Exciting proof-of-principle successes 
have already been achieved in awakening cryptic 
secondary metabolites [10]. 
It has been known for over a century that the 
overwhelming majority of microbial species do 
not grow on synthetic media (in-vitro) and 
remain unexplored [9]. The rRNA and meta-
genomics approaches demonstrated a spectacular 
diversity of these uncultivated species. Accessing 
this “missing” microbial diversity is of significant 
interest for both basic and applied sciences and 
has been recognized as one of the principal 
challenges for microbiology today [10]. In recent 
years, technical advances in cultivation 
methodologies have recovered a diverse set of 
ecologically relevant species [11]. However, by 
and large, the gap between microbial diversity in 
nature and that in culture collections remains 
unchanged, and most microbial phyla still have 
no cultivable representatives [12]. One of the 
oldest unresolved microbiological phenomena is 
why only a small fraction of the microbiological 
population grows on artificial media. The 
“uncultivable” microbial majority arguably 
represents our planet’s largest unexplored pool 
of biological and chemical novelty. Here we 
utilize this approach and develop a novel 
platform for parallel cultivation and isolation of 
previously uncultivated microbial species from a 
variety of environments. We followed the simple 
method of isolation of Actinomycetes by using 
the selective media starch casein agar. Microbial 
derived natural products are major sources of 
antibiotics and other medicines, but discovering 
new antibiotic scaffolds and increasing the 
chemical diversity of existing ones are 
formidable challenges. 
Bacteria are known producers of metabolites 
used in pharmaceuticals and industries 
respectively. However the emergence of 
multidrug resistant pathogens has rekindled the 
need to discover new antimicrobials from the 
environment. Among many metabolites, 
antibiotics are one produced by Streptomyces spp. 
which is known to be found around the 
rhizosphere of Alnus nepalensis. The findings of 
this study will therefore shed light on isolating 
and screening of Streptomyces spp. that produces 
antibiotic from the soil around the root of Alnus 
nepalensis. 
The world is facing an ever-increasing problem 
with antibiotic resistant bacteria and we are 
rapidly heading for a post-antibiotic era. There is 
an urgent need to investigate alternative 
treatment options while there are still a few 
antibiotics left. New resistance mechanisms 
emerge and spread globally threatening our 
ability to treat common infectious diseases, 
resulting in death and disability of individuals 
who, until recently, could continue a normal 
course of life. 
Without effective anti-infective treatment, many 
standard medical treatments will fail or turn into 
very high risk procedures. Infections caused by 
resistant microorganisms often fail to respond to 
the standard treatment, resulting in prolonged 
illness, higher health care expenditures, and a 
greater risk of death. When infections become 
resistant to first-line drugs, more expensive 
therapies must be used. A longer duration of 
illness and treatment, often in hospitals, increases 
health care costs as well as the economic burden 
on families and societies. The achievements of 
modern medicine are put at risk by antimicrobial 
resistance. Without effective antimicrobials for 
prevention and treatment of infections, the 
success of organ transplantation, cancer 
chemotherapy and major surgery would be 
compromised. Thus, world urgently needs new 
and more than ever effective antimicrobials in 
order to treat the ever-increasing threat of 
antibiotics resistance. 
Material and Methods 
Sample collection and growth of Actinomycetes 
One gram soil sample was collected from 
random rhizosphere region of Alder tree, 
situated at an altitude of 1580 msl and brought to 
laboratory for optimization by dry heat (100° C 
for 1 hour) and wet heat (80° C for 40 minutes) 
methods. Starch Casein Agar (SCA) media was 
taken as selective media and 10-fold serial 
dilution technique was followed using NaCl. 
Spread plate technique was performed and 
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isolated colonies of Actinomycetes were selected 
and revived for pure culture.   
Isolation and characterization of Actinomycetes 
Identification of Actinomycetes: It was done by 
morphological method. The morphological 
method consists of macroscopic examination and 
characterization. Microscopically the 
actinomycetes isolates were differentiated by 
their colony characters, e.g. size, shape, color, 
consistency etc. Colonies showing white 
powdery characteristics was identified. Isolated 
colonies were sub-cultured to obtain pure 
culture. Actinomycetes were named as NASA 
101 to NASA 115, NASA 201 to NASA 203, 
NASA 301 to NASA 324, NASA 401 to NASA 404 
respectively. 
Primary screening: Perpendicular streak method 
was used to screen Actinomycetes from library 
against all collected MDR [Methicillin Resistant 
Staphylococcus aureus (MRSA), Vancomycin 
Resistant Enterococcus feacalis (VRE), Imepenem 
Resistant Actinobacter baumannii, Imepenem 
resistant E. coli and Vancomycin Resistant 
Klebsiella pneumonia] as well non-MDR (Klebsiella 
pneumonia, S. aureus, Bacillus subtilis, E. coli, E. 
facealis). 
Extraction of antibiotics 
Solid substrate fermentation: 100 gm of rice grain 
was selected for fermentation by pouring in jam 
bottle and mixed with 100 ml buffer solution and 
autoclaved. 40 such jam bottles were made. For 
each NASA culture inoculation of culture was 
done in each bottle and left for 10 days at 28°C in 
environment chamber. This was smashed and 
dried again in environmental chamber and then 
smashed rice was dissolved into 200 ml of 
methanol and ethylacetate on 1:1 ratio. Then this 
was kept on water bath shaker at 28°C for 24 hrs 
at 120 rpm. After 24 hrs the solution was filtered 
from Whatman paper. 
Extraction using Rota vapor:  
Filtrate was taken for extraction and crude 
antibiotic compounds were obtained after use of 
Rota vapor at 60° temperature in 100 rpm. This 
crude compound was in the form of liquid and 
obtained after color phase change. 
Secondary screening: Well diffusion method was 
performed against similar MDR and non-MDR 
freshly grown in Trypton Soya broth for 3 hours. 
MHA media plates were made and 1-4 holes 
were punched; one hole contained solvent 
(methanol and ethylacetate) in ratio of 1:1. Other 
3 holes contained different extract from Rota 
vapor method. All the plates with solvent and 
numbers of extract were left for nearly 1-2 hrs for 
diffusion. Then these plates were swabbed with 
MDR and Non-MDR microorganisms according 
to the requirements. Spread plate technique was 
used for it. One control plate with antibiotic disc 
placed on MHA media was also prepared. These 
spread plates with microorganisms were 
incubated at 37° C for 24 hrs. This plating was 
done for all the extract along with solvent. Then 
zone of inhibition was observed around extract 
holes. 
Results 
 
Figure 1: NASA 101 showing ZOI against MRSA 
We obtain Actinomycetes isolates after primary 
screening from soil of rhizosphere of Alder tree 
found in different sites around Godawari (Table 
1). These Actinomycetes showed antibacterial 
activities when cross-streaked with Non-MDR 
microorganisms and MDR microorganisms. 
Some Actinomycetes showed antibacterial 
activities after primary screening but not after 
secondary screening. NASA 103, NASA 104, 
NASA 105, NASA 106, NASA 107, NASA 109, 
NASA 110, NASA 111, NASA 114, NASA 115, 
NASA 201, NASA 301, NASA 302, NASA 305, 
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Figure 2: NASA 108, 113 showing ZOI against MDR Enterecoccus feacelis 
  
Figure 3: NASA 303, 304, 306, 307, 308, 318 showing ZOI against MDR Klebsiella pneumoniae 
NASA 310, NASA 311, NASA 314, NASA 315, 
NASA 316, NASA 317, NASA 320, NASA 324 
(Table 2 and Table 3).    
Among the 40 isolates of Actinomycetes from 
rhizosphere of alder tree, about 14 isolates 
showed antibacterial activity against different 
MDR bacteria. NASA 101 (Zone of Inhibition- 
ZOI-34mm) was found to inhibit growth of 
MRSA (Figure 1). NASA 108(ZOI-29.66mm) and 
NASA 113(ZOI-26.4mm) showed antibacterial 
activity against Imepenem resistant E. faecalis 
(Figure 2). NASA 303 inhibited both VRE and 
MDR Klebsiella pneumoniae. MDR Klebsiella 
pneumoniae (Figure 3) was inhibited by NASA 
303 (ZOI-34mm), 304 (ZOI-29.7mm), 306 (ZOI-
36mm), 307 (ZOI-32mm), 308 (ZOI-31mm) and 
Table 1: Description of samples collected from different sites of Godawari and number of obtained Actinomycetes 
S.N Sample sites Districts Specific soil sample area Soil depth 
(cm) 
Numbers of isolates and 
their code 
1. J1 Lalitpur Leech prominent area 5 NASA 306, 321 
2. E1 Lalitpur Entrance to Phulchwoki 5 NASA 307, 308, 309 
3. E2 Lalitpur Entrance to Phulchowki 5 NASA 108 
4. O1 Lalitpur Slope area of Phulchowki 5 NASA 113, 304, 313, 312 
5. O11 Lalitpur Slope area of Phulchwoki 5 NASA 303 
6. O3 Lalitpur Slope area of Phulchwoki 5 NASA 318, 319 
7. PP Lalitpur Phulchwoki 5 NASA 101 
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Figure 4: NASA 307, 318, 319 showing ZOI against 
Imipenem resistant E. coli 
318 (ZOI-28.5mm). NASA 307 (ZOI-22.7mm) also  
showed antibacterial activity against MDR E. coli 
(Figure 4) so did NASA 318 (ZOI-31.7mm) and 
319 (ZOI-33.7mm). Also, NASA 303 (ZOI-26mm), 
309 (ZOI-25.6mm), 312 (ZOI-20mm), 313 (ZOI-
22mm) and 321 (ZOI-24.6mm) showed 
antibacterial activity against VRE (Figure 5) 
Morphological features for example aerial 
mycelium, substrate mycelium, soluble pigment, 
reverse side and growth of selected 14 strains 
were studied (Table 4). NASA 101 showed ash 
gray aerial mycelium and yellow substrate 
mycelium; soluble pigment was absent and the 
reverse side was whitish gray showing good 
growth (Figure 6).  
Table 2: Primary screening of Actinomycetes for antibacterial activity by perpendicular streak method 
Isolates Non-MDR microorganisms MDR microorganisms 
B. 
subtilius 
E. 
coli 
K. pneumoniae E. faecalis S. 
aureus 
MRSA VRE IpR E. 
coli 
K. 
pneumonia 
NASA 101 + + - - + + - - + + 
NASA 103 + - - - - - - - - + 
NASA 104 - - - - - - - - - + 
NASA 105 - - - - - + - - - + 
NASA 106 + - - - - - - - - - 
NASA 107 + - - - - - - - - + 
NASA 108 + - - + + - - + - - 
NASA 109 + - - - - - - - - + 
NASA 110 + + - - + - - - - + 
NASA 111 - - - - + - - - - - 
NASA 113 + - - - - - - + - - 
NASA 114 - - - - - - - - - - 
NASA 115 + - - + + + + - - + 
NASA 201 + + - + + + + + - + 
NASA 301 - - - - - + + + - - 
NASA 302 + - - - + - - - - + 
NASA 303 - - - - - + + - - - 
NASA 304 + - - - + - - - - + 
NASA 305 + - - - + - - - - + 
NASA 306 - - - - - - - - - - 
NASA 307 - - - + - + - - + + 
NASA 308 + - - - + + - - - + 
NASA 309 - - - - + + - - - - 
NASA 311 - - - - - - - - - - 
NASA 312 + - - - + - - - - + 
NASA 313 - - - - - + - + - - 
NASA 314 + - - - + - - - - + 
NASA 315 + - - - - - - - - + 
NASA 316 + - - - + - - - - - 
NASA 317 - - - - - - - - - - 
NASA 318 - - - - + - - - + + 
NASA 319 + - - - + - - - + - 
NASA 320 + - - - - + - - - + 
NASA 321 + - - - + - + - - - 
NASA 324 - - - - - + - + - - 
NASA 401 - - - - - + + + - - 
NASA 403 - - - - - + - - - - 
NASA 404 - - - - - + + - - - 
= zone of inhibition absent; + = zone of inhibition present 
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Figure 5: NASA 303, 309, 312, 313, 321 showing ZOI against VRE 
Figure 6: Growth of isolated Actinomycetes in SCA 
media 
Discussion 
The rising problem in the treatment of bacterial 
infections can be accounted to the presence of 
pathogens that are resistant to the currently 
available antibiotics and hence these pathogens 
are termed multidrug resistant (MDR) 
pathogens. MDR pathogens reported from Nepal 
includes Escherichia coli [13], Salmonella and 
Shigella species, Escherichia coli,  Salmonella spp., 
Klebsiella pneumoniae, Pseudomonas aeruginosa,  
Citrobacter freundii , Proteus spp [14] , methicillin 
resistant Staphylococcus aureus (MRSA)[15], Vibrio 
cholera [16]. MDR pathogens reported from 
South Asia includes Acinetobacter baumannii, 
  
Pseudomonas aeruginosa, Klebsiella pneumonia [17], 
Shigellasonnei [18] , Escherichia coli [19], Salmonella 
enteric [20]. There is certain resemblance in MDR 
pathogens found in context of Nepal and South 
Asia yet there are differences in resistant levels of 
certain bacteria to different drugs. It shows MDR 
pathogens can be specific to its geographical 
location. Actinomycetes producing Vancomycin 
producing is Streptomyces orientalis [21], 
Methicillin is produced by Penicillium sps. [22] 
and Imepenem by Streptomyces cattleya [23]. Thus, 
Actinomycetes are found to produce drugs such 
as vancomycin, imepenem, etc., due to which we 
selected Actinomycetes in our project. Isolation 
of Actinomycetes from soil was done using a 
different method- pretreatment of soil for 1 week 
by air drying followed by isolation of 
Actinomycetes using selective media composed 
of starch yeast extract agar (SYE), yeast extract-
malt extract agar (ISP2), oatmeal agar (ISP3), 
inorganic salt-starch agar (ISP4), starch-casein 
agar (SCA), glucose asparagine agar (GAA), 
Actinomycete isolation agar (AIA) and marine 
agar (MA)[24], whereas other authors used 
crowded plate method for isolation of 
Actinomycetes [25]. Microbially derived natural 
products are major sources of antibiotics and 
other medicines, but discovering new antibiotic 
scaffolds and increasing the chemical diversity of 
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Table 3: Secondary screening of antibacterial activity of the Actinomycetes isolated 
Isolate No. Name of the Test Organism (Inhibition zone diameter in mm) 
VRE MRSA Imepenem 
Resistant 
Escherichia coli 
VRE Klebsiella 
pneumonia 
Imepenem Resistant 
Enterococcus feacelis 
NASA 101 - 34 - - - 
NASA 108 - - - - 29.66 
NASA 113 - - - - 26.4 
NASA 303 26 - - 34 - 
NASA 304 - - - 29.7 - 
NASA 306 - - - 36 - 
NASA 307 - - 22.7 32 - 
NASA 308 - - - 31 - 
NASA 309 25.6 - - - - 
NASA 312 20 - - - - 
NASA 313 22 - - - - 
NASA 318 - - 31.7 28.5 - 
NASA 319 - - 33.7 - - 
NASA 321 24.6 - - - - 
Table 4: Morphological feature of obtained Actinomycetes 
Symbol of strain Aerial mycelium Substrate 
mycelium 
Soluble 
pigment 
Reverse side Growth 
NASA 101 ash gray Yellow - whitish gray +++ 
NASA 108 whitish gray slimey yellow - whitish gray +++ 
NASA 113 White Gray - yellow gray +++ 
NASA 303 ash gray slimy yellow - dark gray +++ 
NASA 304 White White - dark gray ++ 
NASA 306 ash gray Gray - dark gray +++ 
NASA 307 whitish gray Yellow - slimey yellow +++ 
NASA 308 White Yellow - slimey yellow ++ 
NASA 309 whitish gray slimey yellow - slimey yellow +++ 
NASA 312 ash gray slimey yellow - slimey yellow +++ 
NASA 313 dark gray White - White ++ 
NASA 318 whitish gray White - White +++ 
NASA 319 dark gray White - slimey yellow +++ 
NASA 321 dark gray White - slimey yellow +++ 
- = absent; ++ = moderate growth; +++ = good growth   
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existing ones are formidable challenges. A total 
of 40 isolates of Actinomycetes were obtained, 
among which secondary screening NASA 101 
was found to inhibit MRSA, and NASA 303, 309, 
312, 313, 321 were found to inhibit VRE. MRSA is 
resistant to methicillin antibiotic and NASA 101 
must produce antibiotic of different structure 
than that of methicillin [26]. Similarly, the 
structure of antibiotics produced by NASA 
isolates (Table 3) inhibiting VRE and 
Vancomycin resistant Klebsiella pneumoniae, 
should be of different structure than that of 
vancomycin [26]. Likewise, the structure of 
antibiotics produced by NASA isolates (Table 3) 
showing zone of inhibition to Imipenem resistant 
E. coli and Enterococcus feacalis should be different 
than that of imipenem [26]. From this we can say 
that the class of antibiotics produced by NASA 
isolates may be unique one in its structural and 
functional basis. 
The results of primary and secondary screening 
did not match quite well in our project. Some of 
the strains showing zone of inhibition in primary 
screening did not show inhibition during 
secondary screening (well diffusion method). 
Example: NASA 101, NASA 105, NASA 115, 
NASA 201, NASA 401, NASA 404, NASA 301, 
NASA 313, NASA 321, NASA 324. This may be 
due to the protocol followed for extraction of 
antibiotics, effect of solvent used in extraction 
process. Extraction of secondary metabolites, 
such as antibiotics, are generally done by 
maintaining the compositions of the media 
containing yeast extract, dextrose, starch, casein 
hydrolysates, ammonium sulphate, calcium 
carbonate. This kind of composition leads to 
increased production of antibiotics [27]. 
Antibiotics are also extracted by using nutrient 
broth and the method of chromatography which 
helps in efficient extraction of minute amount of 
antibiotics that may be present in the broth [28]. 
But we extracted antibiotics using fermentation 
followed by Rota vapor technique using solvents 
such as methanol and ethyl- acetate (1:1). Since 
we used SCA media for the primary screening, 
the antibiotics could have expressed quite well.  
However, we used solid substrate fermentation 
method for extraction of antibiotics using rice as 
the media with other chemical supplements 
which may not allow antibiotics to be expressed 
on those isolates [29]. This might be due to the 
differences in morphology of Actinomycetes 
when grown in solid and liquid media as 
filamentous mycelia and fragmenting mycelia 
respectively [30]. In the secondary screening zone 
of inhibitions were observed in NASA 108, 
NASA 303, NASA 307, NASA 308, NASA 309, 
NASA 318, NASA 319 and NASA 321 strains but 
not in the primary screening. This might be due 
to the solid fermentation method of the NASA 
strains on rice medium, favoring more to these 
antibiotics expressing NASA strains on the 
secondary screening than that on SCA medium, 
not favoring them to be expressed during the 
primary screening. Many previous studies have 
reported a high degree of concordance in the 
zone of inhibition between the primary and the 
secondary screening extracts [30]. 
It was found that root soil of the analyzed trees 
such as pine, alder, birch contained more 
microorganisms than soil distal to the roots. 
Thus, we selected the rhizosphere of alder tree, 
the indigenous tree of Nepal. The presented 
analysis of the diversity of Actinomycetes in the 
isolation (different soils and rhizosphere of 
different trees) indicated a lack of significant 
differences between the microorganisms. The 
only sources of isolation which were relatively 
diverse were the root-free soil of birch and the 
birch rhizosphere. The lowest diversity of 
Actinomycetes was found in bulk soil and the 
action rhizal rhizoplane of alder [31]. Multidrug 
resistant bacteria are found in context of Nepal 
that are entirely native to this geographical 
location and thus differs from those found in 
other parts of the world. Hence, we need to 
screen and isolate Actinomycetes that are native 
to this environmental condition as well as novel 
in order combat those MDRs.  
Conclusion 
In this study, we isolated Actinomycetes from 
soil around the roots (rhizosphere) of Alder tree. 
We demonstrated that the rhizosphere of Alder 
tree houses clinically important microorganisms. 
Further study of these isolated strains can be 
done to determine exact molecules responsible 
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for anti-MDR property. Whereas the macroscopic 
morphology of the isolates could merely provide 
presumptive genus identification, 16S rRNA 
assay and subsequent sequencing analysis, in the 
future, may possibly resolve their species level 
identity. Since, MDRs are unique to certain 
geographical locations, Actinomycetes capable of 
combating such MDRs must be prevailed in that 
particular environmental condition. Thus, 
intensive research to isolate such clinically 
significant Actinomycetes must be encouraged 
using indigenous natural resources. 
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